Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.830
+0.080 (2.91%)
At close: Dec 5, 2025, 4:00 PM EST
2.840
+0.010 (0.35%)
After-hours: Dec 5, 2025, 7:29 PM EST
Fortress Biotech Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Fortress Biotech stock have an average target of 16.5, with a low estimate of 16 and a high estimate of 17. The average target predicts an increase of 483.04% from the current stock price of 2.83.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 21, 2025.
Analyst Ratings
The average analyst rating for Fortress Biotech stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $26 → $17 | Strong Buy | Maintains | $26 → $17 | +500.71% | Aug 21, 2025 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $15 → $16 | Strong Buy | Reiterates | $15 → $16 | +465.37% | Mar 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $24 → $26 | Strong Buy | Maintains | $24 → $26 | +818.73% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +748.06% | Jul 19, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
Financial Forecast
Revenue This Year
74.81M
from 57.68M
Increased by 29.71%
Revenue Next Year
111.72M
from 74.81M
Increased by 49.34%
EPS This Year
-0.64
from -2.69
EPS Next Year
-1.60
from -0.64
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 84.7M | 116.3M | |
| Avg | 74.8M | 111.7M | |
| Low | 64.7M | 106.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 46.9% | 55.5% | |
| Avg | 29.7% | 49.3% | |
| Low | 12.1% | 41.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.08 | -0.63 | |
| Avg | -0.64 | -1.60 | |
| Low | -1.16 | -2.49 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.